The background to this themed issue on neuropeptides
TRPV1 and SP: key elements for sepsis outcome?
CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?
Structure–activity relationships for α-calcitonin gene-related peptide
Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists
Can neuropeptides treat obesity? A review of neuropeptides and their potential role in the treatment of obesity
Functionally biased signalling properties of 7TM receptors – opportunities for drug development for the ghrelin receptor
Towards a better cannabis drug
Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ9tetrahydrocannabinol
The serine-threonine kinase p90RSK is a new target of enzastaurin in follicular lymphoma cells
Angiotensin II type 1a receptor signalling directly contributes to the increased arrhythmogenicity in cardiac hypertrophy
Chronic inhibition of cGMP-specific phosphodiesterase 5 suppresses endoplasmic reticulum stress in heart failure
Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users
Plasminogen-stimulated airway smooth muscle cell proliferation is mediated by urokinase and annexin A2, involving plasmin-activated cell signalling
Preclinical evaluation of 4-[3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl]-4-oxo-2-butenoic acid, in a mouse model of lung cancer xenograft